Congresses & Webinars
Tebubio at AACR 2025
Tebubio will be attending the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago, from April 27th to 30th, to present our latest poster showcasing the advanced capabilities
Tebubio at the next ELRIG - Therapeutic Oligonucleotides 2025 congress
We are pleased to announce that Tebubio will attend the next Therapeutic Oligonucleotides 2025 congress organised by ELRIG, on May 14–15, 2025, at AstraZeneca’s R&D site in Gothenburg, Sweden.